Chemical Compound

Voxilaprevir|1535212-07-7|GS9857|UNII-0570F37359|(1R,18R,20R,24S,27S,28S)-24-tert-butyl-N-[(1R,2R)-2-(difluoromethyl)-1-[(1-methylcyclopropyl)sulfonylcarbamoyl]cyclopropyl]-28-ethyl-13,13-difluoro-7-methoxy-22,25-dioxo-2,21-dioxa-4,11,23,26-tetrazapentacyclo[24.2.1.03,12.05,10.018,20]nonacosa-3,5(10),6,8,11-pentaene-27-carboxamide|0570F37359|GS-9857|Voxilaprevir [USAN:INN]|Voxilaprevir (USAN/INN)|C40H52F4N6O9S|CHEMBL4474855|SCHEMBL15412621|EX-A5390|DB12026|HY-19840|CS-0017027|J3.665.048F|D10899|Q27236086|(1aR,5S,8S,9S,10R,22aR)-5-tert-butyl-N-[(1 R,2R)-2-(difluoromethyl)-1-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}cyclopropyl]-9-ethyl-18,18-difluoro-14- methoxy-3,6-dioxo-1,1a,3,4,5,6,9,1 0,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19]|L9P

CAS Registry Number 1535212-07-7
Voxilaprevir|1535212-07-7|GS9857|UNII-0570F37359|(1R,18R,20R,24S,27S,28S)-24-tert-butyl-N-[(1R,2R)-2-(difluoromethyl)-1-[(1-methylcyclopropyl)sulfonylcarbamoyl]cyclopropyl]-28-ethyl-13,13-difluoro-7-methoxy-22,25-dioxo-2,21-dioxa-4,11,23,26-tetrazapentacyclo[24.2.1.03,12.05,10.018,20]nonacosa-3,5(10),6,8,11-pentaene-27-carboxamide|0570F37359|GS-9857|Voxilaprevir [USAN:INN]|Voxilaprevir (USAN/INN)|C40H52F4N6O9S|CHEMBL4474855|SCHEMBL15412621|EX-A5390|DB12026|HY-19840|CS-0017027|J3.665.048F|D10899|Q27236086|(1aR,5S,8S,9S,10R,22aR)-5-tert-butyl-N-[(1 R,2R)-2-(difluoromethyl)-1-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}cyclopropyl]-9-ethyl-18,18-difluoro-14- methoxy-3,6-dioxo-1,1a,3,4,5,6,9,1 0,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19]|L9P 结构式
Primary record

Voxilaprevir|1535212-07-7|GS9857|UNII-0570F37359|(1R,18R,20R,24S,27S,28S)-24-tert-butyl-N-[(1R,2R)-2-(difluoromethyl)-1-[(1-methylcyclopropyl)sulfonylcarbamoyl]cyclopropyl]-28-ethyl-13,13-difluoro-7-methoxy-22,25-dioxo-2,21-dioxa-4,11,23,26-tetrazapentacyclo[24.2.1.03,12.05,10.018,20]nonacosa-3,5(10),6,8,11-pentaene-27-carboxamide|0570F37359|GS-9857|Voxilaprevir [USAN:INN]|Voxilaprevir (USAN/INN)|C40H52F4N6O9S|CHEMBL4474855|SCHEMBL15412621|EX-A5390|DB12026|HY-19840|CS-0017027|J3.665.048F|D10899|Q27236086|(1aR,5S,8S,9S,10R,22aR)-5-tert-butyl-N-[(1 R,2R)-2-(difluoromethyl)-1-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}cyclopropyl]-9-ethyl-18,18-difluoro-14- methoxy-3,6-dioxo-1,1a,3,4,5,6,9,1 0,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19]|L9P

库存
2,311 克
纯度
99.6 %
CAS
1535212-07-7

化合物标识与属性

CAS
1535212-07-7
PubChem CID
89921642
SMILES
CC[C@@H]1[C@@H]2CN([C@@H]1C(=O)N[C@@]3(C[C@H]3C(F)F)C(=O)NS(=O)(=O)C4(CC4)C)C(=O)[C@@H](NC(=O)O[C@@H]5C[C@H]5CCCCC(C6=NC7=C(C=C(C=C7)OC)N=C6O2)(F)F)C(C)(C)C
Canonical SMILES
CC[C@@H]1[C@@H]2CN(C(=O)[C@H](C(C)(C)C)NC(=O)O[C@@H]3C[C@H]3CCCCC(F)(F)c3nc4ccc(OC)cc4nc3O2)[C@@H]1C(=O)N[C@]1(C(=O)NS(=O)(=O)C2(C)CC2)C[C@H]1C(F)F

名称与同义词

  • Voxilaprevir
  • voxilaprevirum
  • Voxilaprevir?
  • Voxilaprevir [INN]
  • 1535212-07-7
  • Voxilaprevir [USAN:INN]
  • GS9857
  • RefChem:902060
  • VOXILAPREVIR [MI]
  • Voxilaprevir (USAN/INN)
  • VOXILAPREVIR [USAN]
  • GS-9857
  • C40H52F4N6O9S
  • VOXILAPREVIR [WHO-DD]
  • DTXSID301027947
  • orb1306836
  • CHEMBL4474855
  • SCHEMBL15412621
  • SCHEMBL30965848
  • MZBLZLWXUBZHSL-FZNJKFJKSA-N
  • UNII-0570F37359
  • DTXCID201513515
  • VOXILAPREVIR [ORANGE BOOK]
  • EX-A5390
  • VOSEVI COMPONENT VOXILAPREVIR
  • MFCD32174311
  • AKOS032946110
  • DB12026
  • GS 9857
  • DA-59050
  • HY-19840
  • 0570F37359
  • CS-0017027
  • NS00073626
  • J3.665.048F
  • D10899
  • G16857
  • (1R,18R,20R,24S,27S,28S)-24-tert-butyl-N-[(1R,2R)-2-(difluoromethyl)-1-[(1-methylcyclopropyl)sulfonylcarbamoyl]cyclopropyl]-28-ethyl-13,13-difluoro-7-methoxy-22,25-dioxo-2,21-dioxa-4,11,23,26-tetrazapentacyclo[24.2.1.03,12.05,10.018,20]nonacosa-3,5(10),6,8,11-pentaene-27-carboxamide
  • A1013063
  • Q27236086
  • (1aR,5S,8S,9S,10R,22aR)-5-tert-butyl-N-[(1 R,2R)-2-(difluoromethyl)-1-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}cyclopropyl]-9-ethyl-18,18-difluoro-14- methoxy-3,6-dioxo-1,1a,3,4,5,6,9,1 0,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19]
  • (1aR,5S,8S,9S,10R,22aR)-5-tert-butyl-N-[(1R,2R)-2-(difluoromethyl)-1-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}cyclopropyl]-9-ethyl-18,18-difluoro-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxamide
  • (1R,18R,20R,24S,27S,28S)-24-tert-butyl-N-((1R,2R)-2-(difluoromethyl)-1-((1-methylcyclopropyl)sulfonylcarbamoyl)cyclopropyl)-28-ethyl-13,13-difluoro-7-methoxy-22,25-dioxo-2,21-dioxa-4,11,23,26-tetrazapentacyclo(24.2.1.03,12.05,10.018,20)nonacosa-3,5(10),6,8,11-pentaene-27-carboxamide
  • (1R,18R,20R,24S,27S,28S)-24-tert-butyl-N-[(1R,2R)-2-(difluoromethyl)-1-[(1-methylcyclopropylsulfonyl)carbamoyl]cyclopropyl]-28-ethyl-13,13-difluoro-7-methoxy-22,25-dioxo-2,21-dioxa-4,11,23,26-tetraazapentacyclo[24.2.1.0(3),(1)(2).0?,(1)?.0(1)?,(2)?]nonacosa-3(12),4,6,8,10-pentaene-27-carboxamide
  • (1R,18R,20R,24S,27S,28S)-24-tert-butyl-N-[(1R,2R)-2-(difluoromethyl)-1-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}cyclopropyl]-28-ethyl-13,13-difluoro-7-methoxy-22,25-dioxo-2,21-dioxa-4,11,23,26-tetraazapentacyclo[24.2.1.03,12.05,10.018,20]nonacosa-3(12),4,6,8,10-pentaene-27-carboxamide
  • (33R,34S,35S,91R,92R,5S)-5-(tert-butyl)-N-((1R,2R)-2-(difluoromethyl)-1-(((1-methylcyclopropyl)sulfonyl)carbamoyl)cyclopropyl)-34-ethyl-14,14-difluoro-17-methoxy-4,7-dioxo-2,8-dioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopropanacyclotetradecaphane-35-carboxamide
  • (3S,7R,9R,26R,27S,28S)-28-[[1alpha-[[(1-Methylcyclopropyl)sulfonylamino]carbonyl]-2alpha-(difluoromethyl)cyclopropane-1-yl]aminocarbonyl]-3-tert-butyl-14,14-difluoro-20-methoxy-27-ethyl-6,25-dioxa-1,4,16,23-tetraazapentacyclo[24.2.1.07,9.015,24.017,22]nonacosane-15,17(22),18,20,23-pentaene-2,5-dione
  • 8H-7,10-METHANOCYCLOPROPA(18,19)(1,10,3,6)DIOXADIAZACYCLONONADECINO(11,12-B)QUINOXALINE-8-CARBOXAMIDE, N-((1R,2R)-2-(DIFLUOROMETHYL)-1-((((1-METHYLCYCLOPROPYL)SULFONYL)AMINO)CARBONYL)CYCLOPROPYL)-5-(1,1-DIMETHYLETHYL)-9-ETHYL-18,18-DIFLUORO-1,1A,3,4,5,6,9,10,18,19,20,21,22,22A-TETRADECAHYDRO-14-METHOXY-3,6-DIOXO-, (1AR,5S,8S,9S,10R,22AR)-
  • Cyclopropanecarboxamide, N-((((1R,2R)-2-(5,5-difluoro-5-(3-hydroxy-6-methoxy-2-quinoxalinyl)pentyl)cyclopropyl)oxy)carbonyl)-3-methyl-L-valyl-(3S,4R)-3-ethyl-4-hydroxy-L-prolyl-1-amino-2-(difluoromethyl)-N-((1-methylcyclopropyl)sulfonyl)-, cyclic (1->2)-ether, (1R,2R)-
  • L9P
  • N/A
  • Voxilaprevir|1535212-07-7|GS9857|UNII-0570F37359|(1R,18R,20R,24S,27S,28S)-24-tert-butyl-N-[(1R,2R)-2-(difluoromethyl)-1-[(1-methylcyclopropyl)sulfonylcarbamoyl]cyclopropyl]-28-ethyl-13,13-difluoro-7-methoxy-22,25-dioxo-2,21-dioxa-4,11,23,26-tetrazapentacyclo[24.2.1.03,12.05,10.018,20]nonacosa-3,5(10),6,8,11-pentaene-27-carboxamide|0570F37359|GS-9857|Voxilaprevir [USAN:INN]|Voxilaprevir (USAN/INN)|C40H52F4N6O9S|CHEMBL4474855|SCHEMBL15412621|EX-A5390|DB12026|HY-19840|CS-0017027|J3.665.048F|D10899|Q27236086|(1aR,5S,8S,9S,10R,22aR)-5-tert-butyl-N-[(1 R,2R)-2-(difluoromethyl)-1-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}cyclopropyl]-9-ethyl-18,18-difluoro-14- methoxy-3,6-dioxo-1,1a,3,4,5,6,9,1 0,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19]|L9P